Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol-sodium citrate versus heparin for prevention of hemodialysis catheter infection and dysfunction
IRCT20201108049311N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ethanol, trisodium citrate and heparin in catheter infection and catheter dysfunction (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Clinical signs of catheter infection and Catheter venous blood culture. Started Oct 2020; status: completed.
02
Drugs
ethanoltrisodium citrateheparin
03
Conditions
catheter infectioncatheter dysfunction
Beyond the preview
Go deeper on IRCT20201108049311N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201108049311N6.